News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Osivax Initiates First-in-Human Trial for Sarbecovirus Vaccine Candidate OVX033 with First Participant Vaccination
Friday, February 16, 2024Osivax a company specializing in biopharmaceuticals has launched its Phase trial for OVX a broadspectrum sarbecovirus vaccine candidate The trial marks a significant step forward as the first participant receives the vaccination
Numab Therapeutics and Ono Pharmaceutical Co., Ltd. Announce Collaboration Agreement for the Development of Multispecific Antibody NM49 in Cancer Treatment
Thursday, February 15, 2024Numab Therapeutics AG and Ono Pharmaceutical Co Ltd have jointly announced a collaboration to globally research develop and commercialize NM a multispecific antibody
GSK Opts to License Elsie Biotechnologies’ Discovery Platform for Novel Oligonucleotide Research and Development
Wednesday, February 14, 2024Elsie Biotechnologies Inc made an announcement today that GSK plc has exercised its option for a nonexclusive license to Elsies discovery platform This decision follows a successful research collaboration
Biogen Obtains European Commission Approval for SKYCLARYS® (omaveloxolone), the Initial Therapy for Friedreich’s Ataxia
Tuesday, February 13, 2024Biogen Inc has announced that SKYCLARYS has received authorization from the European Commission EC for the treatment of Friedreichs ataxia in adults and adolescents aged years and older
Multiply Labs and Thermo Fisher Scientific Enhance Collaboration for Automated Cell Expansion and Separation in Cell Therapy Manufacturing
Monday, February 12, 2024Thermo Fisher Scientific has made significant strides in advancing cell therapy development and manufacturing through a collaboration with Multiply Labs robotic technology This partnership aims to enhance efficiency
Corvus Pharmaceuticals Receives Orphan Drug Designation for Soquelitinib in Treating T Cell Lymphoma
Friday, February 09, 2024Corvus Pharmaceuticals Inc has announced today that the US Food and Drug Administration has granted Orphan Drug Designation for soquelitinib a clinicalstage biopharmaceutical companys lead ITK inhibitor candidate
SmartCella Receives GMP Approval for Manufacturing and Quality Control Testing of Cell Therapies
Thursday, February 08, 2024SmartCellas subsidiary ProCella has received approval from the Swedish Medicinal Product Agency for the manufacturing and quality control testing of sterile biological medicinal products for cell therapy
Halia Therapeutics Partners with Canary Speech to Utilize Advanced AI-Driven Speech Technology for Developing Novel Therapeutics Targeting Neuroinflammation
Wednesday, February 07, 2024Halia Therapeutics a company specializing in neuroinflammationtargeting drugs and Canary Speech a leader in artificial intelligence vocal biomarker technology have announced a collaboration
Linnea SA of Switzerland and State University of Campinas (Unicamp) in Brazil Form Strategic Alliance to Advance Cannabinoid Research
Wednesday, February 07, 2024Linnea SA a distinguished global manufacturer of Active Pharmaceutical Ingredients with over four decades of experience and a wellestablished presence in the Latin American region is thrilled to announce the initiation of a strategic partnership
Bayer AG Partners with TetraScience to Boost Innovation through Enhanced Scientific Data Utilization
Tuesday, February 06, 2024Bayer AG a renowned global pharmaceutical and biotechnology company has entered into a partnership with TetraScience a leading provider of Scientific Data and AI Cloud solutions This collaboration aims to optimize the utilization of scientific data
